HC Wainwright Has Pessimistic Outlook of ALGS Q1 Earnings
Aligos Therapeutics, Inc. (NASDAQ:ALGS – Free Report) – Equities research analysts at HC Wainwright reduced their Q1 2025 earnings per share estimates for shares of Aligos Therapeutics in a report issued on Tuesday, March 11th. HC Wainwright analyst E. Arce now expects that the company will post earnings of ($2.37) per share for the quarter, […]
Aligos Therapeutics, Inc. (NASDAQ:ALGS – Free Report) – Equities research analysts at HC Wainwright reduced their Q1 2025 earnings per share estimates for shares of Aligos Therapeutics in a report issued on Tuesday, March 11th. HC Wainwright analyst E. Arce now expects that the company will post earnings of ($2.37) per share for the quarter, […]
